Filing Flows › InfuSystem Holdings (INFU) › Q2 2026 › vs Q1 2026
InfuSystem Holdings (INFU) Q2 2026 vs Q1 2026 (quarter over quarter)
InfuSystem Holdings's revenue rose $3.2M (+10%) from $33.7M in Q1 2026 to $36.9M in Q2 2026. Gross margin 58.0% against 58.4% (-0.5 pts).
InfuSystem Holdings, Q2 2026: revenue $36.9M (+3% year over year), operating margin 11.2%, net earnings $3.2M, operating cash flow $6.8M. The chart draws each line against Q1 2026, the increases inside each band.
Margins
| Q2 2026 | Q1 2026 | Change | |
|---|---|---|---|
| Gross margin | 58.0% | 58.4% | -0.5 pts |
| Operating margin | 11.2% | 4.7% | +6.5 pts |
| Net margin | 8.7% | 3.0% | +5.7 pts |
| Free cash flow margin | 18.1% | 2.4% | +15.7 pts |
Every line
| Line | Q2 2026 | Q1 2026 | Change | % |
|---|---|---|---|---|
| Revenue | $36.9M | $33.7M | $3.2M | +10% |
| Gross profit | $21.4M | $19.7M | $1.7M | +9% |
| Cost of revenue | $15.5M | $14.0M | $1.5M | +11% |
| Operating profit | $4.2M | $1.6M | $2.6M | +161% |
| Operating expenses | $17.3M | $18.1M | −$831K | -5% |
| Pre-tax earnings | $3.9M | $1.4M | $2.5M | +173% |
| Other expense, net | $281K | $173K | $108K | +62% |
| Sales & marketing | $3.0M | $3.1M | −$91K | -3% |
| General & admin | $14.1M | $14.8M | −$706K | -5% |
| Other operating costs | $175K | $209K | −$34K | -16% |
| Net earnings | $3.2M | $1.0M | $2.2M | +218% |
| Income tax | $640K | $400K | $240K | +60% |
| Depreciation & amortization | $3.2M | $3.3M | −$78K | -2% |
| Share-based compensation | $1.2M | $1.2M | $9K | +0.7% |
| Working capital & other | $871K | $4.5M | −$3.7M | -81% |
| Operating cash flow | $6.8M | $970K | $5.8M | +599% |
| Free cash flow (OCF − capex) | $6.7M | $813K | $5.9M | +722% |
| Capital expenditures | $91K | $157K | −$66K | -42% |
Questions
How much did InfuSystem Holdings's revenue grow quarter over quarter in Q2 2026?
InfuSystem Holdings's revenue rose $3.2M (+10%) from $33.7M in Q1 2026 to $36.9M in Q2 2026. Gross margin 58.0% against 58.4% (-0.5 pts).